Paediatric phaeochromocytoma and paraganglioma: A clinical update.

Clin Endocrinol (Oxf)

Developmental Endocrinology, Metabolism, Genetics and Endocrine Oncology Affinity Group, Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Published: November 2024

Paediatric phaeochromocytomas and paragangliomas (PPGLs), though rare tumours, are associated with significant disability and death in the most vulnerable of patients early in their lives. However, unlike cryptogenic and insidious disease states, the clinical presentation of paediatric patients with PPGLs can be rather overt, allowing early diagnosis, granted that salient findings are recognized. Additionally, with prompt and effective intervention, prognosis is favourable if timely intervention is implemented. For this reason, this review focuses on four exemplary paediatric cases, succinctly emphasizing the now state-of-the-art concepts in paediatric PPGL management.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.14955DOI Listing

Publication Analysis

Top Keywords

paediatric
5
paediatric phaeochromocytoma
4
phaeochromocytoma paraganglioma
4
paraganglioma clinical
4
clinical update
4
update paediatric
4
paediatric phaeochromocytomas
4
phaeochromocytomas paragangliomas
4
paragangliomas ppgls
4
ppgls rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!